| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0005516> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0008963> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0025914> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0025929> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0026809> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0035222> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0086589> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162416> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162488> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162489> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162490> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162491> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0162492> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0164371> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0206015> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0748355> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0751318> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C0852283> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33200717_HAS_TOPIC_C5392184>
?:authorAffiliation	[\'Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia and Charlie Norwood VA Medical Center, Augusta, GA 30912, United States.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Kadry_Rana> <https://research.tib.eu/covid-19/entity/Newsome_Andrea_Sikora> <https://research.tib.eu/covid-19/entity/Somanath_Payaningal_R>
?:doi	10.2174/1871526520666201116100310
?:doi	<https://research.tib.eu/covid-19/entity/10.2174/1871526520666201116100310>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Infectious disorders drug targets
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33200717> <https://research.tib.eu/covid-19/entity/rqxaugi7>
?:pmid	<https://research.tib.eu/covid-19/entity/33200717>
?:pmid	33200717
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0035222_PROCESS_OF_C0026809> <https://research.tib.eu/covid-19/entity/C0035222_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C0683317_PROCESS_OF_C0030705> <https://research.tib.eu/covid-19/entity/C1723257_DISRUPTS_C0035222>
?:title	Pharmacological Inhibition of MMP3 as a Potential Therapeutic Option for COVID-19 Associated Acute Respiratory Distress Syndrome.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33200717>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33200717>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all